ResourceDrug discovery > Lead Discovery
How are label-free technologies used in early drug discovery?
15 Feb 2021While traditional biochemical analysis methods such as ELISA and western blots are still used in drug discovery, more and more scientists are adapting label-free analytical techniques in their workflows. In this application note, Sartorius outlines the features of the Octet® system that makes it ideal for lead selection in early drug discovery. To learn how BLI technology on the Octet® is designed to significantly reduce the time it takes to identify, select and optimize therapeutic drug candidates, download the full article below.
Related products
Request Quote for All Products
Octet® R8 BLI System
Sartorius GroupSuperior quantitation and kinetics performance with increased assay flexibility and cost efficiency.
Links
Tags
Compound AnalysisCompound analysis is used to discover specific compounds that could be promising candidates for pharmaceutical use. This potential is identified when compounds have the desired effect, such as interaction with a target protein, during high throughput screening.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Label-Free AnalysisDrug DevelopmentDrug development refers to the process of bringing a new drug to market.